Methylprednisolone for Infants with Neuroendocrine Cells Hyperplasia

We are studying whether methylprednisolone pulses can reduce the need for oxygen therapy in infants with NEHI. The trial also examines the treatment's effects on respiratory health and quality of life.

>2 years 6-10 visits Efficacy phase (II)No Placebo Partially Remote Standard Medicines InjectionInternal MedicinePulmonology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Lidocaine Hydrochloride Monohydrate

Lidocaine hydrochloride monohydrate is a local anesthetic substance used to numb skin and tissues for minor procedures and pain relief.

Methylprednisolone

Methylprednisolone is a corticosteroid that reduces inflammation and calms an overactive immune system.

Methylprednisolone Acetate

Methylprednisolone acetate is a corticosteroid substance used to reduce inflammation and suppress immune responses.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Centre Hospitalier Universitaire D'Angers

Pédiatrie

Angers, France

Centre Hospitalier Universitaire De Toulouse

Pneumopédiatrie

Blagnac, France

Centre Hospitalier Universitaire De Bordeaux

Pédiatrie

Bordeaux, France

Sponsor: Assistance Publique Hopitaux De Paris

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.